The Patent Finder

L-Base Co., Ltd.

5 patents currently held · Updated Nov 21, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Dec 2035
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

No maintenance fee falls due on this company's record before Nov 21, 2027.

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 5 of 5

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 10,233,221Peptide Having Eight Amino Acid Sequences Derived from Cage and Retaining Anticancer Activity and Activity to Promote Anticancer Drug Sensitivity of Anticancer Drug-Resistant Cancer Cells
In force
 · Low confidence
In forceLow confidence
US 10,239,924Peptide Having Eight Amino Acid Sequences Derived from Cage and Retaining Anticancer Activity and Activity to Promote Anticancer Drug Sensitivity of Anticancer Drug-Resistant Cancer Cells
In force
 · High confidence
In forceHigh confidence
US 10,716,826Compositions for overcoming anti-cancer drug-resistance or compositions for anti-cancer activity employing CAGE-derived peptides
In force
 · USPTO record
In forceUSPTO record
US 10,766,926Composition for autophagy inhibiting in cell, and pharmaceutical composition for preventing or treating tumor disease, or inhibiting anti-cancer agents resistance containing the same
In force
 · USPTO record
In forceUSPTO record
US 12,048,730Pharmaceutical composition for preventing or treating cancer, containing oligopeptide as active ingredient
In force
 · USPTO record
In forceUSPTO record

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

1 pending · 1 abandoned · 3 no status recorded

Showing 1 to 5 of 5, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.

ApplicationTitleFiledStatus
18/692,883Sep 16, 2022No status recorded
18/550,775Pharmaceutical Composition for Enhancing Anticancer Effect of Anticancer DrugMar 16, 2022Abandoned
17/996,875Pharmaceutical Composition for Preventing or Treating CancerFeb 25, 2022Pending
16/945,382Jul 31, 2020No status recorded
17/608,263Apr 29, 2020No status recorded
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited